Biotech Live from ASH 2023 | Results from Chinese Studies of Olverembatinib Presented in Oral Report at the ASH Annual Meeting for the Sixth Consecutive Year, Including Data Showing Promising Efficacy in Patients with TKI-Resistant and/or Intolerant CML-CP December 13, 2023
Biotech Biocomposites exceeds revenue expectations and takes a big step forward in its research and development December 13, 2023
Biotech Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH December 12, 2023
Biotech Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer December 12, 2023
Biotech Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients December 1, 2023
Biotech Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio December 1, 2023
Biotech Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023 December 1, 2023
Biotech Calliditas initiates clinical study to evaluate setanaxib in Alport Syndrome November 30, 2023
Search
Biotech
December 13, 2023
December 13, 2023
December 12, 2023
December 12, 2023
December 12, 2023
December 1, 2023
December 1, 2023
December 1, 2023
December 1, 2023
